Loading…

Loading grant details…

Active HORIZON European Commission

Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cord

€3.54M EUR

Funder European Commission
Recipient Organization Agencia Estatal Consejo Superior de Investigaciones Cientificas
Country Spain
Start Date Jan 01, 2023
End Date Dec 31, 2026
Duration 1,460 days
Number of Grantees 7
Roles Participant; Coordinator
Data Source European Commission
Grant ID 101098597
Grant Description

Piezo4Spine aims to develop a novel multifactorial therapy for spinal cord injury (SCI) conceived as a disruptive platform enabling unprecedented multiscale actuation to drive functional neural repair by more accurately tackling SCI complexity.

It originally relies on the pivotal role that mechanotransduction plays in the physiology and physiopathology of tissue and organ functions, never explored before for SCI.

We will develop a 3D bioprinted mesh containing nanocarriers with therapeutic agents acting at two pivotal aspects of neural repair: mechanotransduction and inhibitory scarring using gene therapy strategies.

Bioactive nanocarriers will base on cutting-edge nanoparticles whose release will be electrically triggered on-demand via wireless powering.

Such 3D-theramesh offers a novel and exceptionally robust biomaterial for delivering agents at the lesion, controlling time and dose.

Current advances on SCI therapies focus on rehabilitation, cell transplantation, drugs, biomaterials, and/or electrical stimulation.

Although leading to partial sensory/motor recovery, chronic functional deficits limit daily living activities and shorten live expectancy in SCI patients, as they fail to promote successful axon regeneration at the lesion and awake lost functions.

By a multidisciplinary consortium combining scientific, technological, clinical and industrial partners enriched by their interdisciplinarity, we envision to overcome limitations of current technologies by tackling multiple cellular targets involved in neural regeneration after SCI with a balanced combination of therapeutic interventions able to optimally promote functional recovery.

These radical science-to-technology breakthroughs could enable, if successful, novel technologies and therapies for SCI and many other neural and non-neural pathologies in which some, but not necessarily all, of these targets are involved. Gender dimension will be implemented by ensuring that findings apply to society as a whole.

All Grantees

Acib Gmbh; Servicio de Salud de Castilla la Mancha; Black Drop Biodrucker Gmbh; Universite Catholique de Louvain; Agencia Estatal Consejo Superior de Investigaciones Cientificas; Fondazione Istituto Italiano Di Tecnologia; Universidade de Coimbra

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant